Variant report

Variant	esv1806233
Chromosome Location	chr19:53511977-53553963
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:224)
CpG islands
(count:366)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:224 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr19:53518961-53519336	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr19:53548078-53548353	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr19:53520045-53520364	IMR90	lung:	n/a	n/a
4	CEBPB	chr19:53520072-53520352	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr19:53520052-53520352	K562	blood:	n/a	n/a
6	CEBPB	chr19:53514709-53514946	Hela-S3	cervix:	n/a	chr19:53514790-53514801
7	CEBPB	chr19:53520162-53520365	MCF-7	breast:	n/a	n/a
8	CEBPB	chr19:53514683-53514869	A549	lung:	n/a	chr19:53514790-53514801
9	CEBPB	chr19:53514645-53514955	HepG2	liver:	n/a	chr19:53514790-53514801
10	CEBPB	chr19:53514622-53514961	K562	blood:	n/a	chr19:53514790-53514801
11	CTCF	chr19:53538670-53538733	GM10248	blood:	n/a	n/a
12	CTCF	chr19:53522860-53523010	K562	blood:	n/a	n/a
13	CTCF	chr19:53523070-53523239	NHEK	skin:	n/a	n/a
14	CTCF	chr19:53523000-53523150	SK-N-SH_RA	brain:	n/a	n/a
15	CTCF	chr19:53523053-53523226	Fibrobl	skin:	n/a	n/a
16	CTCF	chr19:53523080-53523230	GM12878	blood:	n/a	n/a
17	CTCF	chr19:53523020-53523170	RPTEC	kidney:	n/a	n/a
18	CTCF	chr19:53522895-53523274	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr19:53513738-53514155	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr19:53517831-53517893	GM10266	blood:	n/a	n/a
21	CTCF	chr19:53523113-53523185	ProgFib	skin:	n/a	n/a
22	CTCF	chr19:53523100-53523250	GM12866	blood:	n/a	n/a
23	CTCF	chr19:53523060-53523210	GM12867	blood:	n/a	n/a
24	CTCF	chr19:53523080-53523230	BE2_C	brain:	n/a	n/a
25	CTCF	chr19:53523040-53523190	Hela-S3	cervix:	n/a	n/a
26	CTCF	chr19:53523080-53523230	GM12874	blood:	n/a	n/a
27	CTCF	chr19:53523084-53523245	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr19:53523060-53523210	HL-60	blood:	n/a	n/a
29	CTCF	chr19:53523000-53523150	HEK293	kidney:	n/a	n/a
30	CTCF	chr19:53523099-53523282	Lung_OC	lung:	n/a	n/a
31	CTCF	chr19:53513900-53514050	HepG2	liver:	n/a	n/a
32	CTCF	chr19:53523000-53523150	HA-sp	spinal cord:	n/a	n/a
33	CTCF	chr19:53517968-53518032	K562	blood:	n/a	n/a
34	CTCF	chr19:53523141-53523173	Spleen_OC	spleen:	n/a	n/a
35	CTCF	chr19:53523155-53523191	LNCaP	prostate:	n/a	n/a
36	CTCF	chr19:53523158-53523228	GM13977	blood:	n/a	n/a
37	CTCF	chr19:53523100-53523250	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr19:53523040-53523190	HUVEC	blood vessel:	n/a	n/a
39	CTCF	chr19:53523114-53523192	GM10266	blood:	n/a	n/a
40	CTCF	chr19:53523060-53523210	WI-38	lung:	n/a	n/a
41	CTCF	chr19:53523060-53523210	HEK293	kidney:	n/a	n/a
42	CTCF	chr19:53523097-53523100	GM19239	blood:	n/a	n/a
43	CTCF	chr19:53522989-53523273	K562	blood:	n/a	n/a
44	CTCF	chr19:53547820-53547970	GM12875	blood:	n/a	n/a
45	CTCF	chr19:53523060-53523210	AG09309	skin:	n/a	n/a
46	CTCF	chr19:53522967-53523271	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr19:53522940-53523416	MCF-7	breast:	n/a	n/a
48	CTCF	chr19:53523073-53523220	MCF-7	breast:	n/a	n/a
49	CTCF	chr19:53523066-53523228	Medullo	brain:	n/a	n/a
50	CTCF	chr19:53522863-53523276	K562	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:53538687-53538737	ovcar-3	ovarian:	n/a
2	chr19:53541186-53541236	HRE	kidney:	n/a
3	chr19:53538883-53538933	SK-N-MC	brain:	n/a
4	chr19:53540902-53540952	HMEC	breast:	n/a
5	chr19:53541287-53541337	HEEpiC	esophagus:	n/a
6	chr19:53541186-53541236	RPTEC	kidney:	n/a
7	chr19:53540902-53540952	Caco-2	colon:	n/a
8	chr19:53538687-53538737	HUVEC	blood vessel:	n/a
9	chr19:53541287-53541337	HRPEpiC	eye:	n/a
10	chr19:53540845-53540895	U87	brain:	n/a
11	chr19:53541186-53541236	HUVEC	blood vessel:	n/a
12	chr19:53541287-53541337	T-47D	breast:	n/a
13	chr19:53540902-53540952	SK-N-SH_RA	brain:	n/a
14	chr19:53540902-53540952	HCF	heart:	n/a
15	chr19:53540902-53540952	CMK	blood:	n/a
16	chr19:53541186-53541236	MCF10A-Er-Src	breast:	n/a
17	chr19:53540845-53540895	ProgFib	skin:	n/a
18	chr19:53540902-53540952	ovcar-3	ovarian:	n/a
19	chr19:53540902-53540952	ProgFib	skin:	n/a
20	chr19:53541186-53541236	LNCaP	prostate:	n/a
21	chr19:53541186-53541236	HCT-116	colon:	n/a
22	chr19:53540845-53540895	HCM	heart:	n/a
23	chr19:53538883-53538933	HEEpiC	esophagus:	n/a
24	chr19:53541287-53541337	PANC-1	pancreas:	n/a
25	chr19:53540845-53540895	Hela-S3	cervix:	n/a
26	chr19:53538883-53538933	HL-60	blood:	n/a
27	chr19:53540902-53540952	LNCaP	prostate:	n/a
28	chr19:53538883-53538933	HepG2	liver:	n/a
29	chr19:53538883-53538933	HEK293	kidney:	embryo
30	chr19:53538687-53538737	HAEpiC	amniotic membrane:	n/a
31	chr19:53538687-53538737	SAEC	small airway:	n/a
32	chr19:53541287-53541337	HUVEC	blood vessel:	n/a
33	chr19:53541287-53541337	Caco-2	colon:	n/a
34	chr19:53538883-53538933	NHBE	bronchial:	n/a
35	chr19:53538883-53538933	GM12892	blood:	n/a
36	chr19:53541186-53541236	GM06990	blood:	n/a
37	chr19:53541186-53541236	SK-N-SH_RA	brain:	n/a
38	chr19:53538883-53538933	AG04450	lung:	fetal
39	chr19:53540845-53540895	HEK293	kidney:	embryo
40	chr19:53538687-53538737	U87	brain:	n/a
41	chr19:53538687-53538737	LNCaP	prostate:	n/a
42	chr19:53540845-53540895	Hepatocyte	liver:	n/a
43	chr19:53541186-53541236	HEEpiC	esophagus:	n/a
44	chr19:53541186-53541236	NHDF-neo	bronchial:	n/a
45	chr19:53541287-53541337	ECC-1	luminal epithelium:	n/a
46	chr19:53541287-53541337	GM12878	blood:	n/a
47	chr19:53540902-53540952	H1-hESC	embryonic stem cell:	embryo
48	chr19:53538883-53538933	HCPEpiC	choroid plexus:	n/a
49	chr19:53541287-53541337	HNPCEpiC	eye:	n/a
50	chr19:53540845-53540895	PrEC	prostate:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:53536567..53539141-chr19:53540653..53542425,2	K562	blood:
2	chr19:53514929..53517284-chr19:53527300..53529548,2	MCF-7	breast:
3	chr19:53515874..53517968-chr19:53519511..53521544,2	K562	blood:
4	chr10:9353360..9353955-chr19:53525559..53526530,2	MCF-7	breast:
5	chr19:53237008..53239147-chr19:53540786..53542527,2	MCF-7	breast:
6	chr19:53541069..53542606-chr19:53543581..53546044,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF816-2	chr19:53540978-53541136	NONHSAT067613
2	lnc-ZNF160-1	chr19:53517584-53517806	ENSG00000251255
3	lnc-ZNF160-1	chr19:53517843-53519833	ENSG00000251255

No data

Variant related genes	Relation type
ERVV-1	TF binding region
ERVV-2	TF binding region
ZNF702P	TF binding region
ERVV-1	CpG island
ERVV-2	CpG island
ZNF702P	CpG island
ENSG00000242779	chromatin interactions
ENSG00000269526	chromatin interactions
ENSG00000213020	chromatin interactions
GPR107	miRNA target sites
RNF4	miRNA target sites

Extended variants
information (count: 1480 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1480 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145407983	chr19:53512001-53512002	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs368620251	chr19:53512003-53512004	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs537470885	chr19:53512012-53512013	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs537898503	chr19:53512094-53512095	Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs1617479	chr19:53512120-53512121	Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs575745675	chr19:53512228-53512229	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs148705712	chr19:53512237-53512238	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs186831756	chr19:53512254-53512255	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs573226879	chr19:53512300-53512301	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs540544482	chr19:53512360-53512361	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs142279431	chr19:53512389-53512390	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs576837385	chr19:53512412-53512413	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs544335108	chr19:53512422-53512423	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs535157569	chr19:53512427-53512428	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs376500202	chr19:53512451-53512452	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs563047983	chr19:53512474-53512475	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs191250752	chr19:53512492-53512493	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs185774793	chr19:53512540-53512541	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs560460461	chr19:53512559-53512560	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs527556473	chr19:53512571-53512572	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552516771	chr19:53512593-53512594	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs1661904	chr19:53512625-53512626	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs140591308	chr19:53512664-53512665	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs549600577	chr19:53512688-53512689	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs568179630	chr19:53512725-53512726	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs536420353	chr19:53512779-53512780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs555115387	chr19:53512790-53512791	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs115304787	chr19:53512803-53512804	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs145727392	chr19:53512807-53512808	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs116901210	chr19:53512810-53512811	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs146722569	chr19:53512813-53512814	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs1650932	chr19:53512815-53512816	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs562828699	chr19:53512832-53512833	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs140301219	chr19:53512875-53512876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs541983219	chr19:53512881-53512882	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs560356156	chr19:53512909-53512910	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs375266428	chr19:53512950-53512951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs188641139	chr19:53512974-53512975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs371728338	chr19:53513003-53513004	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs34073577	chr19:53513022-53513023	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs564411561	chr19:53513030-53513031	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs531188795	chr19:53513037-53513038	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs549775388	chr19:53513077-53513078	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs375982775	chr19:53513082-53513083	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs267605647	chr19:53513108-53513109	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs1661903	chr19:53513141-53513142	Enhancers Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs535498729	chr19:53513160-53513161	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs117406422	chr19:53513165-53513166	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs372980190	chr19:53513174-53513175	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs566678943	chr19:53513197-53513198	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Melanoma	17363583	CNVD
Breast cancer	21785460	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:229 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:53508000-53513200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:53511200-53512600	Enhancers	Placenta Amnion	Placenta Amnion
3	chr19:53511400-53512000	Weak transcription	Right Ventricle	heart
4	chr19:53511600-53512200	Enhancers	Skeletal Muscle Male	skeletal muscle
5	chr19:53511800-53512000	Flanking Active TSS	Placenta	Placenta
6	chr19:53511800-53512400	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr19:53512000-53512200	Active TSS	Placenta	Placenta
8	chr19:53512200-53512400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr19:53512200-53512400	Flanking Active TSS	Placenta	Placenta
10	chr19:53512200-53512400	Enhancers	Right Ventricle	heart
11	chr19:53512400-53512600	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr19:53512400-53513000	Enhancers	Placenta	Placenta
13	chr19:53512400-53513200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
14	chr19:53512400-53513400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr19:53512600-53514200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr19:53512600-53518800	Weak transcription	Placenta Amnion	Placenta Amnion
17	chr19:53513000-53513800	Genic enhancers	Placenta	Placenta
18	chr19:53513200-53513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr19:53513200-53513600	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr19:53513400-53514000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr19:53513400-53514200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr19:53513600-53513800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
23	chr19:53513800-53514000	Flanking Active TSS	Placenta	Placenta
24	chr19:53513800-53514200	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr19:53514000-53514200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr19:53514000-53516600	Enhancers	Placenta	Placenta
27	chr19:53514200-53518800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr19:53516600-53517200	Genic enhancers	Placenta	Placenta
29	chr19:53517200-53518600	Weak transcription	Placenta	Placenta
30	chr19:53518600-53519400	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr19:53518600-53519400	Genic enhancers	Placenta	Placenta
32	chr19:53518800-53519200	Genic enhancers	Placenta Amnion	Placenta Amnion
33	chr19:53518800-53519400	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
34	chr19:53519200-53519400	Enhancers	Placenta Amnion	Placenta Amnion
35	chr19:53519400-53519800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
36	chr19:53519400-53520400	Weak transcription	Placenta Amnion	Placenta Amnion
37	chr19:53519400-53520600	Enhancers	Placenta	Placenta
38	chr19:53519800-53520200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
39	chr19:53520400-53520600	Enhancers	Placenta Amnion	Placenta Amnion
40	chr19:53520400-53520800	Enhancers	Osteobl	bone
41	chr19:53522600-53523400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
42	chr19:53527800-53528000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr19:53528000-53538600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr19:53529400-53530000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr19:53529600-53529800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr19:53530000-53540400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr19:53531000-53531200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr19:53531000-53531800	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr19:53531200-53532000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
50	chr19:53531600-53532200	Enhancers	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links